Muireann Bolger

Key details

Muireann Bolger is deputy editor of World Intellectual Property Review and Life Sciences Intellectual Property Review in London, where she covers trademarks, brands, as well as wider developments across the intellectual property sector.

She regularly attends and covers major IP conferences around the world, reporting on the latest legal, commercial and policy developments and interviewing leading figures from across the sector. She has also co-authored industry reports with leading IP organisations, including the International Trademark Association (INTA).

She is the editor of the website’s Community & Inclusion channel and the annual Influential Women in IP list, which celebrates the achievements and contributions of leading women across the IP sector.

Originally from Ireland, Muireann has nearly two decades of experience reporting on brand developments, strategy, and wider business issues.

In her current role, she writes and edits news and analysis for an international audience of IP professionals, while also championing inclusion within the profession.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 415

Articles by Muireann Bolger

'Scrap the billable hour': LSIPR joins INTA panel on gender diversity
Americas
A lively session explored findings from a report co-authored by LSIPR sister title WIPR, urging the IP sector to call time on outdated metrics that delay or derail women’s professional progress.   22 May 2025
INTA unveils key principles on AI and IP rights at Annual Meeting
Americas
The International Trademark Association launches a regulatory framework for AI at the Annual Meeting in San Diego | Adopted Resolution highlights importance of human oversight in IP decisions.   20 May 2025
Mayer Brown welcomes patent litigator in Washington, DC
Careers
New addition from ArentFox Schiff brings expertise in consumer electronics, semiconductors, software, and pharmaceuticals.   13 May 2025
Americas
Decision follows director review ordered by Kathi Vidal two years ago | Two pieces of prior art successfully cited in arguments key to invalidation.   6 May 2025
Americas
Case looked at whether generic treatment infringes ‘fridge temperature limitation method’ | Ruling underscores importance of clear labelling in drug patent infringement suits.   24 April 2025
Americas
As the US legal sector comes under political pressure for its inclusion efforts, LSIPR's sister magazine reveals its Top 100 for 2025, highlighting the individuals fighting to keep progress at the heart of IP.   24 April 2025
Americas
With a career spanning an iconic consumer brand and big pharma, INTA's current president is focused on amplifying the voice of in-house counsel, finds Muireann Bolger.   22 April 2025
Pharma
Ruling overturns earlier decision allowing generic drug maker to launch version | Dispute centres on $300-million dollar treatment for diabetes, chronic heart failure and kidney disease—currently protected by a challenged SPC.   10 April 2025
Europe
The pressures of IP law can take a serious toll on mental wellbeing. Boult Wade Tennant partner and WIPR Diversity Champion, Susi Fish, shares her experiences and tips for managing stress.   3 April 2025
Americas
Complaint centres on AI-powered tools for cancer diagnostics | Tempus says its rival has a history of deliberately copying competitors’ technologies.   18 March 2025

Not finding what you're looking for, please try resetting your applied search and filters,
or try the
full site search.